欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号MT/H/0393/001
药品名称Micafungin 50 mg powder for concentrate for solution for infusion
活性成分
    • Micafungin sodium salt 50.0 mg
剂型Powder for concentrate for solution for infusion
上市许可持有人Viatris Limited Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland
参考成员国 - 产品名称Malta (MT)
Micafungin 50 mg powder for concentrate for solution for infusion
互认成员国 - 产品名称
    • Germany (DE)
      Micafungin Mylan 50 mg, Pulver zur Herstellung einer Infusionslösung
    • Netherlands (NL)
      Micafungine Mylan 50 mg, poeder voor concentraat voor oplossing voor infusie
    • United Kingdom (Northern Ireland) (XI)
      Micafungin 50 mg powder for solution for
    • France (FR)
      Micafungine Mylan 50 mg, poudre pour solution pour perfusion
    • Portugal (PT)
      Micafungina Mylan
    • Italy (IT)
      Micafungin Mylan
    • Sweden (SE)
      Micafungine Mylan
    • Norway (NO)
      Micafungine Mylan
    • Poland (PL)
      Micafungin Mylan
许可日期2020/06/11
最近更新日期2024/10/24
药物ATC编码
    • J02AX05 micafungin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase